NodThera

Description: NodThera develops selective NLRP3 inflammasome inhibitors to treat chronic inflammation disorders, with teams in Cambridge, Seattle, and Lexington.

Country: UK

Based in: Little Chesterford

Founded: 2016

Funding Stage: Series A/B

Tags: ['Biotechnology', 'Health Care', 'Life Science']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.